311 related articles for article (PubMed ID: 8602222)
1. Characterization of a cancer cachectic factor.
Todorov P; Cariuk P; McDevitt T; Coles B; Fearon K; Tisdale M
Nature; 1996 Feb; 379(6567):739-42. PubMed ID: 8602222
[TBL] [Abstract][Full Text] [Related]
2. Comparison of animal models for head and neck cancer cachexia.
Cannon T; Couch M; Yin X; Guttridge D; Lai V; Shores C
Laryngoscope; 2007 Dec; 117(12):2152-8. PubMed ID: 17921906
[TBL] [Abstract][Full Text] [Related]
3. Catabolic factors in cancer cachexia.
Tisdale MJ; McDevitt TM; Todorov PT; Cariuk P
In Vivo; 1996; 10(2):131-6. PubMed ID: 8744791
[TBL] [Abstract][Full Text] [Related]
4. Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.
Graves E; Hitt A; Pariza MW; Cook ME; McCarthy DO
Res Nurs Health; 2005 Feb; 28(1):48-55. PubMed ID: 15625711
[TBL] [Abstract][Full Text] [Related]
5. The 'cancer cachectic factor'.
Tisdale MJ
Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice.
Yasumoto K; Mukaida N; Harada A; Kuno K; Akiyama M; Nakashima E; Fujioka N; Mai M; Kasahara T; Fujimoto-Ouchi K
Cancer Res; 1995 Feb; 55(4):921-7. PubMed ID: 7850809
[TBL] [Abstract][Full Text] [Related]
7. Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma.
Matsumoto T; Fujimoto-Ouchi K; Tamura S; Tanaka Y; Ishitsuka H
Br J Cancer; 1999 Feb; 79(5-6):764-9. PubMed ID: 10070867
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia.
Belizário JE; Lorite MJ; Tisdale MJ
Br J Cancer; 2001 Apr; 84(8):1135-40. PubMed ID: 11308266
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans.
McDevitt TM; Todorov PT; Beck SA; Khan SH; Tisdale MJ
Cancer Res; 1995 Apr; 55(7):1458-63. PubMed ID: 7882353
[TBL] [Abstract][Full Text] [Related]
10. Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft.
Tamura S; Ouchi KF; Mori K; Endo M; Matsumoto T; Eda H; Tanaka Y; Ishitsuka H; Tokita H; Yamaguchi K
Clin Cancer Res; 1995 Nov; 1(11):1353-8. PubMed ID: 9815931
[TBL] [Abstract][Full Text] [Related]
11. Changes in nucleic acid and protein levels in atrophying skeletal muscle in cancer cachexia.
Bhogal AS; Lorite ML; Tisdale MJ
Anticancer Res; 2006; 26(6B):4149-54. PubMed ID: 17201126
[TBL] [Abstract][Full Text] [Related]
12. Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice.
Kawamura I; Lacey E; Yamamoto N; Sakai F; Takeshita S; Inami M; Nishigaki F; Naoe Y; Tsujimoto S; Manda T; Shimomura K; Goto T
Anticancer Res; 1999; 19(5B):4105-11. PubMed ID: 10628361
[TBL] [Abstract][Full Text] [Related]
13. Induction of muscle protein degradation and weight loss by a tumor product.
Todorov PT; McDevitt TM; Cariuk P; Coles B; Deacon M; Tisdale MJ
Cancer Res; 1996 Mar; 56(6):1256-61. PubMed ID: 8640810
[TBL] [Abstract][Full Text] [Related]
14. Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factor.
Hussey HJ; Todorov PT; Field WN; Inagaki N; Tanaka Y; Ishitsuka H; Tisdale MJ
Br J Cancer; 2000 Jul; 83(1):56-62. PubMed ID: 10883668
[TBL] [Abstract][Full Text] [Related]
15. Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.
Strassmann G; Fong M; Freter CE; Windsor S; D'Alessandro F; Nordan RP
J Clin Invest; 1993 Nov; 92(5):2152-9. PubMed ID: 8227330
[TBL] [Abstract][Full Text] [Related]
16. Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.
Negri DR; Mezzanzanica D; Sacco S; Gadina M; Benigni F; Cajola L; Finocchiaro G; Ghezzi P; Canevari S
Cytokine; 2001 Jul; 15(1):27-38. PubMed ID: 11509006
[TBL] [Abstract][Full Text] [Related]
17. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
Kuroda K; Horiguchi Y; Nakashima J; Kikuchi E; Kanao K; Miyajima A; Ohigashi T; Umezawa K; Murai M
Clin Cancer Res; 2005 Aug; 11(15):5590-4. PubMed ID: 16061877
[TBL] [Abstract][Full Text] [Related]
18. Waste management - cytokines, growth factors and cachexia.
Saini A; Al-Shanti N; Stewart CE
Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
[TBL] [Abstract][Full Text] [Related]
19. Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host.
Beck SA; Tisdale MJ
Cancer Res; 1987 Nov; 47(22):5919-23. PubMed ID: 3311359
[TBL] [Abstract][Full Text] [Related]
20. [Role of NF-kappa B in cancer cachexia].
Zhou W; Jiang ZW; Jiang J; Li N; Li JS
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):683-6. PubMed ID: 15329260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
